peplexicon
Choose your depth

Context, anatomy, and key evidence

← Peptide library

mitochondrial-derived peptide

MOTS-c

Published evidence · coverage incomplete
Anatomical contextAnatomy connections are not mapped yet.

No body region is highlighted until this profile has a supported anatomical connection. This does not mean the peptide has no biological effects.

Read published mechanism findings ↓

At a glance

What is it—and why does it matter?

An introduction is not yet available. The findings below address specific research questions, not a complete account of this peptide.

This published profile is a reference in progress. Findings retain their source context; missing topics are marked below.

What is it?

A molecule, not a product name.

Identity

MOTS-C is defined here by its expansion as “mitochondrial ORF of the 12S rRNA type-c,” indicating its naming is tied to a mitochondrial open reading frame (ORF) within the 12S rRNA context.

Sources[1]pubmedSafety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.MOTS-C (mitochondrial ORF of the 12S rRNA type-c)
Source records
1
Independent studies
1

Evidence boundary: Applies only to the source-defined population, formulation, dose, and assessment period.

Exact passages, locators, and provenance
  1. supports · Source-backed record
    “MOTS-C (mitochondrial ORF of the 12S rRNA type-c)”

    Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. · Abstract

    pubmed:41966639:9547b381c1d2:9547b381c1d2

How does it work?

Target, response, and disposition.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

What has been studied?

What the evidence says.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Risks and interactions

Risks, organized for scanning.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Products and regulatory status

Same ingredient. Different records.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Administration context

The practical clinical context.

This profile does not yet contain a published summary for this topic. This is a coverage gap, not evidence that no research exists.

Research status + gaps

What still needs better answers?

  • No publishable claim yet for: administration, contraindication, effect, interaction, mechanism, regulatory, safety
  • 1 compiled claim(s) withheld by automated assurance: assurance_score_below_0.72 (1), current_regulatory_source_required (1), extraction_ambiguity (1), high_risk_requires_regulatory_or_two_independent_sources (1), no_direct_support (1)

These are the limits of this profile, not an exhaustive list of scientific uncertainties.

References + discovery

Open the records yourself.

  1. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance. ↗

    pubmed · published 2026-08-01 · retrieved 2026-08-17T23:10:15Z

Publication history and provenance

Version 1 · Automated assessment · 2026-08-17T23:10:15Z

a122ed7c294a6bbdf4faa93dc035607ad1cdebeae5dd17eec15c276782eefe9f